- Published on
Toxicology – Calcium Channel Blocker Toxicity
Source
Calcium channel blockers (CCBs) include medications such as verapamil, diltiazem, amlodipine, nifedipine, nicardipine, and felodipine. These drugs are commonly prescribed for conditions like hypertension, arrhythmias, angina, migraines, and Raynaud’s phenomenon.
Typical Presentation
Toxicity often occurs after accidental ingestion, especially in children, or intentional overdose. Patients may present with cardiovascular instability along with gastrointestinal symptoms.
Clinical Features
Key findings include bradycardia, varying degrees of heart block, hypotension, nausea, vomiting, constipation, and ileus. Hyperglycemia is a distinguishing feature due to impaired insulin release. Severe cases may involve altered mental status secondary to reduced cerebral perfusion.
Mechanism of Action
CCBs inhibit L-type calcium channels in cardiac and smooth muscle. In vascular smooth muscle, this leads to vasodilation and hypotension. In the heart, they decrease sinoatrial and atrioventricular nodal conduction (negative chronotropic effect) and reduce contractility (negative inotropic effect). In pancreatic cells, calcium channel blockade decreases insulin secretion, resulting in elevated blood glucose levels.
Management
Treatment is supportive and requires close cardiac monitoring. Interventions may include intravenous fluids, calcium (calcium gluconate or calcium chloride), high-dose insulin therapy with glucose supplementation, glucagon, vasopressors, and lipid emulsion therapy in severe cases. Whole bowel irrigation may be considered for sustained-release ingestions. Advanced measures such as transvenous pacing or intra-aortic balloon pump support may be required in refractory cases.
Key Points
Source
Calcium channel blockers (CCBs) include medications such as verapamil, diltiazem, amlodipine, nifedipine, nicardipine, and felodipine. These drugs are commonly prescribed for conditions like hypertension, arrhythmias, angina, migraines, and Raynaud’s phenomenon.
Typical Presentation
Toxicity often occurs after accidental ingestion, especially in children, or intentional overdose. Patients may present with cardiovascular instability along with gastrointestinal symptoms.
Clinical Features
Key findings include bradycardia, varying degrees of heart block, hypotension, nausea, vomiting, constipation, and ileus. Hyperglycemia is a distinguishing feature due to impaired insulin release. Severe cases may involve altered mental status secondary to reduced cerebral perfusion.
Mechanism of Action
CCBs inhibit L-type calcium channels in cardiac and smooth muscle. In vascular smooth muscle, this leads to vasodilation and hypotension. In the heart, they decrease sinoatrial and atrioventricular nodal conduction (negative chronotropic effect) and reduce contractility (negative inotropic effect). In pancreatic cells, calcium channel blockade decreases insulin secretion, resulting in elevated blood glucose levels.
Management
Treatment is supportive and requires close cardiac monitoring. Interventions may include intravenous fluids, calcium (calcium gluconate or calcium chloride), high-dose insulin therapy with glucose supplementation, glucagon, vasopressors, and lipid emulsion therapy in severe cases. Whole bowel irrigation may be considered for sustained-release ingestions. Advanced measures such as transvenous pacing or intra-aortic balloon pump support may be required in refractory cases.
Key Points
- Mental status may initially remain normal despite significant cardiovascular compromise.
- Hyperglycemia helps differentiate CCB toxicity from beta-blocker overdose.
- ECG findings may include PR prolongation, sinus arrest, or high-grade heart block.
- Atropine may be attempted for bradycardia but is often ineffective.
- Published on
Toxicology – Fire Ant (Formicidae) Envenomation
Source
Ants belong to the Formicidae family within the Hymenoptera order. Fire ants, particularly the red imported fire ant (RIFA), are an aggressive invasive species commonly found in the southern United States. These ants live in large, highly organized colonies and can attack in groups when disturbed.
Typical Presentation
Envenomation typically occurs when a person disturbs an ant mound, leading to multiple simultaneous stings. Victims often report sudden intense burning pain followed by visible skin lesions.
Clinical Features
Each sting produces immediate pain and a small raised wheal. Within 24 hours, these lesions evolve into characteristic pustules. The affected areas are often itchy, and scratching may lead to secondary infection or scarring. In some individuals, especially those with hypersensitivity, systemic allergic reactions including anaphylaxis may occur.
Mechanism of Action
Fire ant venom contains alkaloid compounds, particularly piperidine derivatives, which cause local tissue irritation and inflammation. The venom also includes components capable of triggering allergic responses in susceptible individuals.
Management
Treatment involves removal from the exposure source and supportive care. Topical corticosteroids and oral antihistamines can help relieve inflammation and itching. In cases of allergic reactions, appropriate management—including epinephrine for anaphylaxis—should be initiated. Antibiotics may be required if secondary infection develops.
Key Points
Source
Ants belong to the Formicidae family within the Hymenoptera order. Fire ants, particularly the red imported fire ant (RIFA), are an aggressive invasive species commonly found in the southern United States. These ants live in large, highly organized colonies and can attack in groups when disturbed.
Typical Presentation
Envenomation typically occurs when a person disturbs an ant mound, leading to multiple simultaneous stings. Victims often report sudden intense burning pain followed by visible skin lesions.
Clinical Features
Each sting produces immediate pain and a small raised wheal. Within 24 hours, these lesions evolve into characteristic pustules. The affected areas are often itchy, and scratching may lead to secondary infection or scarring. In some individuals, especially those with hypersensitivity, systemic allergic reactions including anaphylaxis may occur.
Mechanism of Action
Fire ant venom contains alkaloid compounds, particularly piperidine derivatives, which cause local tissue irritation and inflammation. The venom also includes components capable of triggering allergic responses in susceptible individuals.
Management
Treatment involves removal from the exposure source and supportive care. Topical corticosteroids and oral antihistamines can help relieve inflammation and itching. In cases of allergic reactions, appropriate management—including epinephrine for anaphylaxis—should be initiated. Antibiotics may be required if secondary infection develops.
Key Points
- Fire ant stings often occur in clusters due to coordinated attacks.
- Lesions typically progress from wheals to pustules within a day.
- Scratching increases the risk of infection and scarring.
- Severe allergic reactions, although less common, can be life-threatening.
- Published on
Toxicology – Hymenoptera Envenomation (Bees, Wasps, Hornets)
Source
Hymenoptera are winged insects that include bees, wasps, hornets, and ants. The Vespidae family (wasps, yellow jackets, hornets) tend to be more aggressive, while the Apidae family (honeybees, bumblebees) are generally less aggressive unless provoked.
Typical Presentation
Patients may present after one or multiple stings, often occurring outdoors. Severe reactions are more likely in cases of multiple stings or in individuals with allergic sensitivity.
Clinical Features
Local reactions include pain, redness, swelling, and warmth at the sting site. Systemic reactions may involve widespread hives (urticaria), wheezing, shortness of breath, chest discomfort, nausea, vomiting, airway swelling (stridor), altered mental status, and in severe cases, shock or coagulopathy. Anaphylaxis can occur even after a single sting in sensitized individuals.
Mechanism of Action
Venom from these insects contains substances such as melittin, histamine, phospholipases, and other mediators that trigger inflammation and mast cell activation. This can lead to allergic reactions ranging from mild to life-threatening.
Management
Treatment is supportive. Any retained stingers should be promptly removed by scraping to prevent further venom release. Anaphylaxis requires immediate administration of epinephrine. Additional therapies may include antihistamines, corticosteroids, intravenous fluids, and inhaled beta-agonists for respiratory symptoms.
Key Points
Source
Hymenoptera are winged insects that include bees, wasps, hornets, and ants. The Vespidae family (wasps, yellow jackets, hornets) tend to be more aggressive, while the Apidae family (honeybees, bumblebees) are generally less aggressive unless provoked.
Typical Presentation
Patients may present after one or multiple stings, often occurring outdoors. Severe reactions are more likely in cases of multiple stings or in individuals with allergic sensitivity.
Clinical Features
Local reactions include pain, redness, swelling, and warmth at the sting site. Systemic reactions may involve widespread hives (urticaria), wheezing, shortness of breath, chest discomfort, nausea, vomiting, airway swelling (stridor), altered mental status, and in severe cases, shock or coagulopathy. Anaphylaxis can occur even after a single sting in sensitized individuals.
Mechanism of Action
Venom from these insects contains substances such as melittin, histamine, phospholipases, and other mediators that trigger inflammation and mast cell activation. This can lead to allergic reactions ranging from mild to life-threatening.
Management
Treatment is supportive. Any retained stingers should be promptly removed by scraping to prevent further venom release. Anaphylaxis requires immediate administration of epinephrine. Additional therapies may include antihistamines, corticosteroids, intravenous fluids, and inhaled beta-agonists for respiratory symptoms.
Key Points
- These stings are a leading cause of fatal envenomation, primarily due to anaphylaxis.
- Severe reactions can occur even with a single sting in allergic individuals.
- Honeybees typically leave behind a barbed stinger, whereas wasps and hornets can sting multiple times.
- Published on
Toxicology – Cone Snail Envenomation
Source
Cone snails are marine predators found in warm and tropical oceans worldwide. There are hundreds of species, many with brightly patterned shells. They use a specialized harpoon-like structure (radula) to inject venom into prey or humans when handled.
Typical Presentation
Exposure typically occurs when a person handles or steps on a cone snail. Patients often report an immediate stinging or burning sensation at the site of contact, followed by progressive neurological symptoms.
Clinical Features
Initial symptoms include localized pain similar to an insect sting, along with burning, numbness, and tingling. As toxicity progresses, patients may develop muscle weakness, difficulty swallowing, blurred vision, and spreading numbness (including lips and tongue). Severe cases can lead to paralysis, shock, and respiratory failure. Some systemic effects may be delayed.
Mechanism of Action
Cone snail venom contains a mixture of peptide toxins known as conotoxins. These compounds primarily affect ion channels and disrupt nerve signaling, leading to neuromuscular dysfunction and paralysis.
Management
There is no specific antidote. Treatment is supportive, with close monitoring of airway and respiratory function. Mechanical ventilation may be required in severe cases until the toxin is cleared. Most symptoms improve within several hours.
Key Points
- Even minor contact can result in envenomation.
- Symptoms may progress from local pain to life-threatening paralysis.
- Some conotoxins are being studied for potential medical applications.
- Although rare, fatalities have been reported.
- Published on
Toxicology – Hyperkalemia (Elevated Potassium Levels)
Source
Elevated potassium levels can result from potassium supplements, kidney failure (especially in dialysis patients), and certain medications such as ACE inhibitors, NSAIDs, and potassium-sparing diuretics. It may also occur due to cellular breakdown in conditions like rhabdomyolysis, hemolysis, or tumor lysis syndrome.
Typical Presentation
Patients may present with vague symptoms such as weakness or fatigue, but serious cases often involve cardiac abnormalities detected on ECG, especially in those with impaired kidney function.
Clinical Features
Symptoms are often nonspecific and may include:
High extracellular potassium alters the electrical gradient across cardiac cells, making them more excitable and prone to dangerous arrhythmias.
Management
Treatment is urgent and involves three main strategies:
Source
Elevated potassium levels can result from potassium supplements, kidney failure (especially in dialysis patients), and certain medications such as ACE inhibitors, NSAIDs, and potassium-sparing diuretics. It may also occur due to cellular breakdown in conditions like rhabdomyolysis, hemolysis, or tumor lysis syndrome.
Typical Presentation
Patients may present with vague symptoms such as weakness or fatigue, but serious cases often involve cardiac abnormalities detected on ECG, especially in those with impaired kidney function.
Clinical Features
Symptoms are often nonspecific and may include:
- Generalized weakness and malaise
- Slow heart rate (bradycardia)
- Cardiac arrhythmias
- Peaked T waves
- Prolonged PR interval
- Flattened or absent P waves
- Widened QRS complex
- “Sine wave” pattern leading to cardiac arrest
High extracellular potassium alters the electrical gradient across cardiac cells, making them more excitable and prone to dangerous arrhythmias.
Management
Treatment is urgent and involves three main strategies:
- Stabilize the heart
- IV calcium (calcium gluconate or calcium chloride) to protect cardiac membranes
- Shift potassium into cells
- Insulin with glucose
- β-agonists (e.g., high-dose nebulized albuterol)
- Sodium bicarbonate (in cases of acidosis)
- Remove potassium from the body
- Dialysis (most effective in severe cases)
- Potassium-binding resins (e.g., sodium polystyrene sulfonate)
- ECG monitoring is essential in suspected hyperkalemia.
- Calcium does not lower potassium—it stabilizes the heart.
- Severe hyperkalemia is a medical emergency due to risk of fatal arrhythmias.
- Kidney function plays a major role in potassium regulation.
- Published on
Toxicology – Lithium Toxicity
Source
Lithium carbonate is commonly prescribed for bipolar disorder. It is also used in industrial settings, including fireworks production.
Typical Presentation
Toxicity may occur from acute overdose, chronic accumulation, or a combination of both. Patients on long-term therapy are especially at risk if kidney function declines or if interacting medications are introduced.
Clinical Features
Lithium toxicity presents in three main patterns:
Lithium affects multiple intracellular pathways, including inhibition of signaling systems and neurotransmitter modulation. It is eliminated almost entirely by the kidneys, making renal function a key factor in toxicity.
Management
Treatment is supportive and focuses on enhancing elimination:
Source
Lithium carbonate is commonly prescribed for bipolar disorder. It is also used in industrial settings, including fireworks production.
Typical Presentation
Toxicity may occur from acute overdose, chronic accumulation, or a combination of both. Patients on long-term therapy are especially at risk if kidney function declines or if interacting medications are introduced.
Clinical Features
Lithium toxicity presents in three main patterns:
- Acute toxicity: Predominantly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and dizziness. Kidney injury and mild cardiac changes (e.g., QT prolongation) may occur.
- Chronic toxicity: Mainly neurological symptoms including tremor, weakness, hyperreflexia, involuntary movements, poor coordination, confusion, and altered consciousness, which can progress to coma.
- Acute-on-chronic toxicity: A combination of both GI and neurological symptoms, often more severe.
Lithium affects multiple intracellular pathways, including inhibition of signaling systems and neurotransmitter modulation. It is eliminated almost entirely by the kidneys, making renal function a key factor in toxicity.
Management
Treatment is supportive and focuses on enhancing elimination:
- IV fluids to improve kidney perfusion and promote excretion
- Whole bowel irrigation for sustained-release ingestion
- Hemodialysis for severe cases (e.g., high lithium levels, neurological symptoms, or kidney impairment)
-
- Toxicity risk increases with dehydration, kidney dysfunction, and certain medications (e.g., NSAIDs, ACE inhibitors).
- Neurological symptoms are more prominent in chronic toxicity.
- Lithium levels may rise again after dialysis, requiring repeated treatments.
- Activated charcoal is not effective for lithium overdose.
- Therapeutic levels are typically 0.6–1.2 mEq/L.
- Published on
Toxicology – Methylxanthine Toxicity (Caffeine, Theophylline, Theobromine)
Source
Methylxanthines include compounds such as caffeine, theophylline (used in respiratory diseases), and theobromine (found in chocolate). These substances are present in beverages, medications, and certain foods.
Typical Presentation
Toxicity often results from overdose—intentional or accidental—and can present with both gastrointestinal and cardiovascular symptoms. Severe cases may rapidly progress to life-threatening complications.
Clinical Features
Early symptoms commonly include headache, nausea, vomiting (often persistent), abdominal discomfort, and diarrhea. As toxicity worsens, patients may develop:
Mechanism of Action
Methylxanthines exert multiple effects:
Management
Treatment is primarily supportive and may include:
Key Points
Source
Methylxanthines include compounds such as caffeine, theophylline (used in respiratory diseases), and theobromine (found in chocolate). These substances are present in beverages, medications, and certain foods.
Typical Presentation
Toxicity often results from overdose—intentional or accidental—and can present with both gastrointestinal and cardiovascular symptoms. Severe cases may rapidly progress to life-threatening complications.
Clinical Features
Early symptoms commonly include headache, nausea, vomiting (often persistent), abdominal discomfort, and diarrhea. As toxicity worsens, patients may develop:
- Rapid heart rate and breathing
- Low blood pressure with wide pulse pressure
- Tremors, agitation, and restlessness
- Seizures, including status epilepticus
- Cardiac arrhythmias (ranging from sinus tachycardia to ventricular fibrillation)
Mechanism of Action
Methylxanthines exert multiple effects:
- Block adenosine receptors (removing inhibitory CNS effects)
- Stimulate β-adrenergic activity, increasing heart rate and blood pressure
- Inhibit phosphodiesterase, leading to increased cAMP and intracellular calcium
Management
Treatment is primarily supportive and may include:
- IV fluids and vasopressors (e.g., norepinephrine or phenylephrine) for hypotension
- Benzodiazepines for seizures
- Management of arrhythmias (often with calcium channel blockers)
- Activated charcoal to reduce absorption
- Whole bowel irrigation for sustained-release ingestions
Key Points
- Severe toxicity can cause persistent vomiting, seizures, and dangerous arrhythmias.
- Theobromine is especially toxic to animals (e.g., dogs, rabbits).
- Dialysis is considered in life-threatening cases.
- Multidose activated charcoal may enhance elimination.
- Published on
Toxicology – Digitalis (Digoxin) Toxicity
Source
Digoxin is a cardiac medication used to manage conditions like atrial fibrillation and heart failure. Similar cardiac glycosides are naturally found in plants such as foxglove, oleander, and milkweed, as well as in certain toads (e.g., Bufo species).
Typical Presentation
Patients—often elderly with underlying heart disease—may present with gastrointestinal complaints, abnormal heart rhythms, and visual disturbances. Toxicity can occur from acute overdose or chronic accumulation.
Clinical Features
Mechanism of Action
Digoxin works by inhibiting the sodium–potassium ATPase pump, which increases intracellular calcium and enhances cardiac contractility. It also increases vagal tone, slowing conduction through the heart. However, these same effects predispose to abnormal heart rhythms in overdose.
Management
Treatment focuses on stabilizing the patient and addressing arrhythmias:
Key Points
Source
Digoxin is a cardiac medication used to manage conditions like atrial fibrillation and heart failure. Similar cardiac glycosides are naturally found in plants such as foxglove, oleander, and milkweed, as well as in certain toads (e.g., Bufo species).
Typical Presentation
Patients—often elderly with underlying heart disease—may present with gastrointestinal complaints, abnormal heart rhythms, and visual disturbances. Toxicity can occur from acute overdose or chronic accumulation.
Clinical Features
- Acute toxicity: Symptoms usually appear several hours after ingestion and include nausea, vomiting, elevated potassium levels, and dangerous cardiac arrhythmias.
- Chronic toxicity: More subtle and varied, including fatigue, confusion, weakness, gastrointestinal upset, and visual changes (e.g., blurred vision, yellow-tinted vision or “xanthopsia”).
Mechanism of Action
Digoxin works by inhibiting the sodium–potassium ATPase pump, which increases intracellular calcium and enhances cardiac contractility. It also increases vagal tone, slowing conduction through the heart. However, these same effects predispose to abnormal heart rhythms in overdose.
Management
Treatment focuses on stabilizing the patient and addressing arrhythmias:
- Supportive care with cardiac monitoring
- Atropine for symptomatic bradycardia
- Correction of electrolyte imbalances (especially potassium and magnesium)
- Activated charcoal if ingestion is recent
- Digoxin-specific antibody fragments (Digoxin immune Fab) for severe toxicity (e.g., life-threatening arrhythmias, high potassium, or hemodynamic instability)
Key Points
- Toxicity can be acute or chronic, with different clinical patterns.
- Visual disturbances are a classic clue.
- Hyperkalemia in acute toxicity is a poor prognostic sign.
- Digoxin levels should be interpreted carefully, especially early after ingestion.
- Antibody therapy is the definitive treatment in severe cases.
- Published on
Toxicology – Levamisole Toxicity (Cocaine Adulterant)
Source
Levamisole is a medication originally used as an antiparasitic agent in veterinary medicine. It is now commonly encountered as an adulterant mixed with cocaine to enhance its appearance and perceived potency.
Typical Presentation
Patients are often individuals with a history of cocaine use who present with unexplained infections or unusual skin findings. Symptoms may develop after repeated exposure.
Clinical Features
A hallmark feature is vasculitis, appearing as purplish skin lesions, often involving the ears, face, and lower limbs. Patients may also experience fever and chills.
Laboratory findings frequently reveal severe neutropenia or agranulocytosis, increasing the risk of serious infections. In some cases, neurological complications such as leukoencephalopathy have been reported.
Mechanism of Action
Levamisole acts as an immunomodulatory agent. In humans, it can suppress bone marrow function in a dose-dependent manner, leading to dangerously low white blood cell counts. Its continued presence in illicit drugs contributes to repeated toxic exposure.
Management
Treatment primarily involves stopping exposure to the contaminated substance and providing supportive care. Management of infections and monitoring of blood counts are essential.
Key Points
Source
Levamisole is a medication originally used as an antiparasitic agent in veterinary medicine. It is now commonly encountered as an adulterant mixed with cocaine to enhance its appearance and perceived potency.
Typical Presentation
Patients are often individuals with a history of cocaine use who present with unexplained infections or unusual skin findings. Symptoms may develop after repeated exposure.
Clinical Features
A hallmark feature is vasculitis, appearing as purplish skin lesions, often involving the ears, face, and lower limbs. Patients may also experience fever and chills.
Laboratory findings frequently reveal severe neutropenia or agranulocytosis, increasing the risk of serious infections. In some cases, neurological complications such as leukoencephalopathy have been reported.
Mechanism of Action
Levamisole acts as an immunomodulatory agent. In humans, it can suppress bone marrow function in a dose-dependent manner, leading to dangerously low white blood cell counts. Its continued presence in illicit drugs contributes to repeated toxic exposure.
Management
Treatment primarily involves stopping exposure to the contaminated substance and providing supportive care. Management of infections and monitoring of blood counts are essential.
Key Points
- Strongly associated with cocaine use due to drug adulteration.
- Causes characteristic purplish skin lesions (vasculitis).
- Can lead to severe immune suppression (agranulocytosis).
- Risk of infection is high due to low white blood cell counts.
- May cause adverse reactions when combined with alcohol.
- Published on
Toxicology – Strychnine Poisoning
Source
Strychnine is a naturally occurring toxin derived from the seeds of the Strychnos nux-vomica tree. It is commonly used in rodenticides and pest control products and may also be found as an adulterant in illicit drugs.
Typical Presentation
Exposure typically follows ingestion or inhalation. Patients often present with sudden onset of severe muscle spasms and convulsions, sometimes after accidental or intentional ingestion of poison products.
Clinical Features
Early signs include anxiety, increased salivation, and dilated pupils. Rapidly, painful muscle spasms begin in the face and neck—manifesting as grimacing (risus sardonicus) and jaw stiffness (trismus)—then spread to the entire body.
Patients develop intense, prolonged muscle contractions (tetany), often with a characteristic arching posture (opisthotonus). Unlike typical seizures, patients may remain conscious and aware during these episodes. Severe complications include:
Strychnine blocks the inhibitory neurotransmitter glycine in the central nervous system, particularly at the spinal cord level. Without glycine’s inhibitory effect, motor neurons become overactive, leading to uncontrolled muscle contractions and spasms.
Management
Treatment is supportive and focused on controlling muscle activity and protecting the airway:
Source
Strychnine is a naturally occurring toxin derived from the seeds of the Strychnos nux-vomica tree. It is commonly used in rodenticides and pest control products and may also be found as an adulterant in illicit drugs.
Typical Presentation
Exposure typically follows ingestion or inhalation. Patients often present with sudden onset of severe muscle spasms and convulsions, sometimes after accidental or intentional ingestion of poison products.
Clinical Features
Early signs include anxiety, increased salivation, and dilated pupils. Rapidly, painful muscle spasms begin in the face and neck—manifesting as grimacing (risus sardonicus) and jaw stiffness (trismus)—then spread to the entire body.
Patients develop intense, prolonged muscle contractions (tetany), often with a characteristic arching posture (opisthotonus). Unlike typical seizures, patients may remain conscious and aware during these episodes. Severe complications include:
- Rhabdomyolysis
- Hyperthermia
- Metabolic (lactic) acidosis
- Respiratory failure due to sustained muscle contraction
Strychnine blocks the inhibitory neurotransmitter glycine in the central nervous system, particularly at the spinal cord level. Without glycine’s inhibitory effect, motor neurons become overactive, leading to uncontrolled muscle contractions and spasms.
Management
Treatment is supportive and focused on controlling muscle activity and protecting the airway:
- Benzodiazepines and barbiturates for seizure and spasm control
- Early intubation with sedation and use of nondepolarizing paralytics (e.g., rocuronium, vecuronium)
- IV fluids for rhabdomyolysis
- Active cooling for hyperthermia
- Patients may remain conscious during severe spasms (“conscious seizures”).
- Avoid succinylcholine, as it can worsen muscle contractions.
- Respiratory failure is a major cause of death.
- Rapid, aggressive supportive care is critical.
